ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
2023 EHA® Insights: "Updated Results of the Ph1/2 VEN-A-QUI Study of Venetoclax + Quizartinib + Aza or LDAC in Newly Diagnosed Unfit AML Patients"
By
ecancer
FEATURING
Juan Miguel Bergua Burgues
By
ecancer
FEATURING
Juan Miguel Bergua Burgues
Login to view comments.
Click here to Login
